Clinical value of gene detection in metastatic prostate cancer
10.3760/cma.j.cn112330-20210908-00005
- VernacularTitle:转移性前列腺癌基因检测的临床应用价值
- Author:
Baijun DONG
1
;
Wei XUE
Author Information
1. 上海交通大学医学院附属仁济医院泌尿科，上海 200127
- Keywords:
Metastatic prostate cancer;
Treatment strategy;
Genetic testing;
Precision oncology
- From:
Chinese Journal of Urology
2021;42(Z2):15-17
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of prostate cancer has increased over the past several years and it has become a major disease that seriously harms male health. Advanced prostate cancer is a heterogeneous disease with poor outcomes, the median overall survival of advanced prostate cancer usually less than two years. Clinical challenges include determining the optimal sequencing of systemic therapies and implementing biomarker-driven treatment approaches. The emergence of precision treatment has brought about a diagnosis and treatment strategy based on molecular testing, which provides the possibility for the formulation of individualized treatment plans.
